Search clinical trials for: Trastuzumab emtansine [Kadcyla]
Total 1168 results
-
NSABP Foundation IncWashington University School of Medicine; Breast Cancer Research FoundationActive, not recruiting
-
Hoffmann-La RocheCompletedBreast CancerUnited Kingdom, Spain, Australia, Sweden
-
National Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Malignancies | Hematologic MalignanciesUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
WiSP Wissenschaftlicher Service Pharma GmbHBristol-Myers Squibb; Roche Pharma AGCompleted
-
SanofiCompletedBreast NeoplasmsFrance, Brazil, Poland, Germany, Belgium, Tunisia, United Kingdom, Uruguay
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, Brazil, China, Italy, Argentina, Jordan, Mexico, Germany, Portugal, Spain, Thailand, United Kingdom, Kenya, Turkey, Hungary, Colombia, India, Oman, Saudi Arabia, Poland, Uganda, United... and more
-
Boehringer IngelheimCompleted
-
National Cancer Institute (NCI)WithdrawnBreast Cancer | Breast Neoplasms | Lung Neoplasms | Lung Cancer
-
Shanghai Changzheng HospitalUnknown
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Genentech, Inc.CompletedHead and Neck CancerUnited States
-
City of Hope Medical CenterActive, not recruitingBreast Cancer | Stage IV Breast CancerUnited States
-
University Medical Center GroningenAmsterdam UMC, location VUmc; University Medical Center NijmegenActive, not recruitingMetastatic Breast CancerNetherlands
-
National Cancer Institute, NaplesActive, not recruitingMetastatic Breast CancerItaly
-
Yonsei UniversityActive, not recruitingRecurrent/Metastatic Gastric CancerKorea, Republic of
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBreast Cancer | Metastatic Breast Cancer | Progressive Breast CancerUnited States
-
Hoffmann-La RocheCompleted
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)Completed
-
Canadian Cancer Trials GroupAstraZenecaCompletedMetastatic Breast CancerCanada
-
Memorial Sloan Kettering Cancer CenterTerminatedGastric Cancer | Esophageal Cancer | Esophageal Neoplasms | Gastroesophageal Junction Cancer | Gastric Tumor | Gastroesophageal Junction Adenocarcinoma | GastroEsophageal Cancer | Esophageal Tumor | Esophagogastric Tumors | Gastroesophageal Junction TumorUnited States
-
Shandong Cancer Hospital and InstituteUnknownMetastatic Breast Cancer | HER2-positive Breast Cancer
-
Cancer Institute and Hospital, Chinese Academy...RecruitingCarcinoma, Transitional Cell | HER-2 Gene AmplificationChina
-
University of WashingtonActive, not recruitingHER2-positive Breast CancerUnited States
-
AryoGen Pharmed Co.Completed
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingBreast CancerNetherlands
-
Taizhou Mabtech Pharmaceutical Co.,LtdCompletedHealthy VolunteersChina
-
Hoffmann-La RocheCompleted
-
Ashkan EmadiCompletedAcute Myeloid LeukemiaUnited States
-
Hoffmann-La RocheTerminated
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheTerminatedGastric CancerGermany, Austria
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada
-
SanofiCompletedBreast Cancer | Breast NeoplasmsUnited States, Spain
-
The Netherlands Cancer InstituteCompletedBreast Cancer | HER2 PositiveNetherlands
-
Danish Breast Cancer Cooperative GroupSanofi; Hoffmann-La RocheUnknown
-
Centre Leon BerardAmgenRecruitingHER2-positive Breast Cancer | Operable Breast CancerFrance
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer; HER2-positive; MetastaticUnited States, Belgium, Canada, Denmark, Italy, Spain, Hungary, Taiwan, Turkey, France, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, United Kingdom, China, South Africa, Israel, Russian Federation, Argentina, ... and more
-
Seagen Inc.Active, not recruitingGastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States, Korea, Republic of, United Kingdom, Taiwan, Canada, Australia
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingFirst-line Treatment | HER2-positive Metastatic Breast CancerChina
-
Wuhan Union Hospital, ChinaRecruitingBreast Cancer | NeoadjuvantChina
-
Fudan UniversityNot yet recruiting
-
Novartis PharmaceuticalsCompletedMetastases, BrainSpain, Hungary, Poland, Germany, Italy, Russian Federation, Sweden, United Kingdom, Thailand, United States, Belgium, France, Greece, Denmark
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Merrimack PharmaceuticalsUnknownBreast CancerUnited States
-
BioInvent International ABActive, not recruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | HER2-positive Metastatic Breast CancerSpain, United Kingdom, Germany
-
Changhoon YooCompletedCholangiocarcinoma | Biliary Tract Cancer | HER-2 Gene Amplification | HER-2 Protein OverexpressionKorea, Republic of
-
SCRI Development Innovations, LLCEisai Inc.CompletedMetastatic Breast CancerUnited States
-
Fudan UniversityRecruitingTreatment EfficacyChina